Clinical Trial Update: Utility of Presepsin in Distinguishing Between Sepsis and SIRS

View source ↗

Summary

Completed clinical trial evaluating presepsin for distinguishing sepsis from SIRS; results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Systemic Inflammatory Response Syndrome

Drugs mentioned

• Presepsin (presepsin)

Snippet

Sponsor: Mochida Pharmaceutical Company, Ltd. | Conditions: SIRS, Sepsis | Status: COMPLETED | Results posted: 2016-09-27